SAN DIEGO, CA — September 9, 2025 — Leads & Copy — Revelation Biosciences, Inc. (NASDAQ:REVB) will host a webcast on September 10th at 8:30 am Eastern Time to review data. The webcast can be accessed here. To call in, dial 888-506-0062 (toll free in the US), +1 973-528-0011 (if International) and use the participant access code 289672.
Revelation Biosciences, Inc. is a clinical stage life sciences company focused on rebalancing inflammation using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as prevention for acute kidney injury and the treatment of chronic kidney disease.
Company Contacts: Mike Porter, Investor Relations, Porter LaVay & Rose Inc., Email: mike@plrinvest.com; Chester Zygmont, III, Chief Financial Officer, Revelation Biosciences Inc., Email: czygmont@revbiosciences.com
Source: Revelation Biosciences
